Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Select coverage from 5th Annual International C. diff Awareness Conference and Health EXPO is included below:

Ridinilazole Shows Superior Efficacy for Treatment of <i>C. diff</i> in Phase 2 Study
Dr. Richard Vickers, discusses how ridinilazole showed superior efficacy for the treatment of C. diff when compared with vancomycin in a phase 2 study.
Preparing to Ensure Effective Stock & Delivery of Future <i>C. diff</i> Vaccine
Richard Haupt, MD, MPH, discusses what is needed to ensure that a future C. diff vaccine is adequately stocked and delivered to wherever individuals show up for vaccination.
Current Guidance for <i>C. diff</i> Disinfection in Health Care Facilities
Barley Chironda, RPN, CIC, discusses current guidance for disinfection practices against C. diff.
Cost-Benefit of Investing in Launderable Mattress Covers to Prevent CDIs
Edmond Hooker, MD, DrPH, discusses the cost benefit of investing in launderable hospital mattress covers to prevent CDIs.
Top Infectious Disease News of the Week—January 7, 2018
In case you missed them, we've compiled the top 5 articles from this past week.
How Does Ridinilazole Compare with Other Antibiotics That Target <i>C. diff</i>?
Dr. Richard Vickers, explains how ridinilazole is unique in its spectrum of activity compared with other antibiotics that target C. diff and have been approved or are in development.
Addressing the Challenges of Implementing Delivery of Future <i>C. diff</i> Vaccine
Richard Haupt, MD, MPH, discusses what would be required to adequately implement the delivery of a future C. diff vaccine.
Breaking the Chain of Infection
Barley Chironda, RPN, CIC, explains what the “chain of infection” is and what is needed to break it.
FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.